Quantifying Innovation: The Measurable Impact of Advanced Heart Preservation
At their industry symposium at ISHLT2026, Paragonix Technologies explored how advanced organ preservation technologies are influencing clinical outcomes, donor utilization, and the future of heart transplantation.
Through the support of Paragonix Technologies, this session is now available for you to view on demand.
Featuring insights from Dr. Nir Uriel, Dr. Daniel Goldstein, Dr. David D'Alessandro, and Dr. Jay Pal, the symposium examines the growing body of evidence supporting controlled hypothermic preservation, including data from the GUARDIAN-Heart Registry, one of the largest real-world datasets evaluating advanced heart preservation.
Topics include:
- Long-term clinical outcomes associated with controlled hypothermic preservation
- The role of temperature management in donor heart protection
- Expanding donor utilization through advanced preservation strategies
- Emerging approaches to DCD heart transplantation and donor recovery
Watch the full symposium to hear how transplant leaders are leveraging clinical evidence, technological innovation, and evolving procurement strategies to help improve outcomes for transplant recipients worldwide.
The content of this recording was developed entirely by our industry partner, Paragonix Technologies. It is not an official educational program of the ISHLT, and therefore is not eligible for CME under the ISHLT.